[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591831":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":21,"centralContacts":21,"locations":21,"responsibleParty":22,"collaborators":21,"id":26,"slug":27,"hasResults":28,"nctId":29,"briefTitle":30,"officialTitle":31,"acronym":21,"eligibilityCriteria":32,"healthyVolunteers":28,"sex":33,"minAge":34,"maxAge":35,"enrollmentInfo":36,"targetDuration":21,"studyType":39,"phases":40,"briefSummary":42,"conditions":43,"keywords":45,"overallStatus":48,"whyStopped":21,"lastUpdateSubmitDate":49,"lastUpdatePostDateStruct":50,"startDateStruct":53,"completionDateStruct":55,"leadSponsor":57,"locationsCount":21},{"fullName":5,"class":6},"Assiut University","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Female diagnosed (clinically and histopatgologically) with IGM not pregnant nor immunocompromised","Ultrasound guided intralesional injection of steroids (Triamicinolone) (40mg\u002Fml ) at site of IGM inflammatory mass after injection of local anesthesia ,once every month and follow up for 6 to 12 months",[12],"Drug: Ultrasound guided intralesional Steroids injection (Triamicinolone)",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","Ultrasound guided intralesional Steroids injection (Triamicinolone)","Radiological guided steroid injection of IGM",[9],[20],"Triamicinolone as (epirelefan ) (ciscortine)",null,{"type":23,"investigatorFullName":24,"investigatorTitle":25,"investigatorAffiliation":5,"oldNameTitle":21,"oldOrganization":21},"PRINCIPAL_INVESTIGATOR","Aghapy Ghobrial Reda","Prinicipal investigator","100591831","phase-1-steroid-injection-in-idiopathic-granulomatous-mastitis-100591831",false,"NCT06985537","Steroid Injection in Idiopathic Granulomatous Mastitis","Efficacy of Ultrasound Guided Intralesional Steroid Injection in Idiopathic Granulomatous Mastitis (IGM)","Inclusion Criteria:\n\n* Women diagnosed with IGM confirmed clinically and histopathologically , willing to undergo intralesional steroid treatment.\n\nExclusion Criteria:\n\n* Patients with active infections.\n* Patients on immunosuppressive therapy.\n* pregnant women.","FEMALE","18 Years","45 Years",{"count":37,"type":38},40,"ESTIMATED","INTERVENTIONAL",[41],"PHASE1","Granulomatous mastitis (GM) is a non-infectious inflammatory breast condition typically affecting young women, often following breastfeeding. Management of GM often begins with anti-inflammatory medications and antibiotics. Steroids, particularly intralesional corticosteroids, are considered the first-line treatment for GM due to their rapid anti-inflammatory and immunosuppressive effects. Steroids help control symptoms such as painful lumps, swelling, and redness. Steroids' effectiveness in providing symptom relief minimizes the need for more invasive treatments such as surgery.",[44],"Idiopathic Granulomatous Mastitis",[46,47],"Idiopathic GM","intralesional steroid injection","NOT_YET_RECRUITING","2025-05-21",{"date":51,"type":52},"2025-05-22","ACTUAL",{"date":54,"type":38},"2025-06",{"date":56,"type":38},"2026-02",{"name":5,"class":6}]